Establishing the Optimal Ceftriaxone MIC for Predicting ESBL Production in Bloodstream Infections.
作者信息
Hareza Dariusz A, Bergman Yehudit, Jacobs Emily, Mathers Amy J, Hauser Alan R, Cosgrove Sara E, Simner Patricia J, Tamma Pranita D
机构信息
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
出版信息
Open Forum Infect Dis. 2025 Aug 14;12(9):ofaf490. doi: 10.1093/ofid/ofaf490. eCollection 2025 Sep.
Abstract
摘要
相似文献
1
Establishing the Optimal Ceftriaxone MIC for Predicting ESBL Production in Bloodstream Infections.
Open Forum Infect Dis. 2025 Aug 14;12(9):ofaf490. doi: 10.1093/ofid/ofaf490. eCollection 2025 Sep.
2
Molecular epidemiology of β-lactamases in ceftriaxone-resistant Enterobacterales bloodstream infections in the mid-Atlantic United States.
Antimicrob Agents Chemother. 2025 Mar 5;69(3):e0125824. doi: 10.1128/aac.01258-24. Epub 2025 Jan 27.
3
Current Ceftriaxone Dose Recommendations are Adequate for Most Critically Ill Children: Results of a Population Pharmacokinetic Modeling and Simulation Study.
Clin Pharmacokinet. 2021 Oct;60(10):1361-1372. doi: 10.1007/s40262-021-01035-9. Epub 2021 May 26.
4
Analysis of Neisseria gonorrhoeae susceptibility trends (MIC creep) from North India: A 15-years' experience!
Indian J Dermatol Venereol Leprol. 2025 Jul-Aug;91(4):432-439. doi: 10.25259/IJDVL_1096_2024.
5
Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum β-Lactamase-Producing Enterobacterales Bloodstream Infections?
Clin Infect Dis. 2024 May 15;78(5):1103-1110. doi: 10.1093/cid/ciad703.
6
Oral and parenteral treatment with a third-generation cephalosporin promotes the proliferation of diverse ESBL-producing in the chicken intestinal tract.
mSphere. 2025 Jun 27:e0022725. doi: 10.1128/msphere.00227-25.
7
Unraveling Ceftriaxone Dosing: Free Drug Prediction, Threshold Optimization, and Model Validation.
AAPS J. 2025 Feb 26;27(2):50. doi: 10.1208/s12248-025-01041-w.
8
Re-evaluation of penicillin and ceftriaxone MIC results to predict susceptibility to the oral cephalosporin, cefpodoxime, in clinical isolates from the United States according to CLSI guidelines (2019-2021).
J Clin Microbiol. 2025 Jun 24:e0002725. doi: 10.1128/jcm.00027-25.
9
Bactericidal activity of antibiotic combinations against clinical isolates of Enterococcus gallinarum and Enterococcus casseliflavus.
J Antimicrob Chemother. 2025 Jun 3;80(6):1519-1525. doi: 10.1093/jac/dkaf095.
10
Dissemination of extended-spectrum beta-lactamase-producing in poultry in Zimbabwe.
Microb Genom. 2025 Jul;11(7). doi: 10.1099/mgen.0.001454.
本文引用的文献
1
Molecular epidemiology of β-lactamases in ceftriaxone-resistant Enterobacterales bloodstream infections in the mid-Atlantic United States.
Antimicrob Agents Chemother. 2025 Mar 5;69(3):e0125824. doi: 10.1128/aac.01258-24. Epub 2025 Jan 27.
2
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.
Clin Infect Dis. 2024 Aug 7. doi: 10.1093/cid/ciae403.
3
Trends of β-Lactamase Occurrence Among and in United States Hospitals During a 5-Year Period and Activity of Antimicrobial Agents Against Isolates Stratified by β-Lactamase Type.
Open Forum Infect Dis. 2023 Jan 27;10(2):ofad038. doi: 10.1093/ofid/ofad038. eCollection 2023 Feb.
4
Interpreting area under the receiver operating characteristic curve.
Lancet Digit Health. 2022 Dec;4(12):e853-e855. doi: 10.1016/S2589-7500(22)00188-1. Epub 2022 Oct 18.
5
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection.
JAC Antimicrob Resist. 2021 Jul 16;3(3):dlab092. doi: 10.1093/jacamr/dlab092. eCollection 2021 Sep.
6
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study.
Clin Infect Dis. 2021 Dec 6;73(11):e3842-e3850. doi: 10.1093/cid/ciaa1479.
7
Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories.
J Clin Microbiol. 2019 May 24;57(6). doi: 10.1128/JCM.00203-19. Print 2019 Jun.
8
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163.
9
Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae.
Antimicrob Agents Chemother. 2013 Oct;57(10):5131-3. doi: 10.1128/AAC.00607-13. Epub 2013 Jul 8.
10
Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam.
Clin Infect Dis. 2013 May;56(9):1301-9. doi: 10.1093/cid/cit017. Epub 2013 Jan 18.
Zotero 插件